Support our sponsors:

NZX 50 Index	3326.74	0.00
S&P/ASX 200	4282.90	7.80
Dow Jones Industrials	12884.00	5.80

Twitter

Facebook

RSS

Daily ShareChat: Fisher and Paykel Healthcare

By Jenny Ruth

Tuesday 15th June 2010

Text too small?

First NZ Capital analyst Sarndra Urlich has downgraded her forecast of Fisher & Paykel Healthcare's 2012 earnings towards the lower end of consensus and her forecast of its 2013 earnings is now well below consensus.

Urlich says her previous forecasts looked high, particularly when compared with the earnings profile of the past few years and expected 2011 earnings.

"In other words, how realistic is our earnings 'hockey stick' scenario?"

In 2012, Urlich now assumes a slightly lower-margin product mix, less favourable exchange rate and has raised her expectation of the company's selling, general and administrative (SG&A) expenses to sell its new ICON range of obstructive sleep apnea treatment machines.

"As a reference point, we would note that Resmed spends around 30% to 31% of its revenues on SG&A," Urlich says. She is now expecting Fisher & Paykel to spend 25.5% of sales, up from 24.2% previously.

She is now forecasting an $86 million net profit for the year ending March 2012, down from $97 million previously.

For 2013, she expects a slightly lower exchange rate and slightly higher margins than in 2012, although the latter is lower than her previous forecast. In part, that reflects her expectation the company will spend 7% of sales on R&D, up from 6% previously. She now expects net profit in the year ended March 2013 will be $105 million, down from $121 million previously.

Recommendation: Underperform.

Daily ShareChat articles report how the main experts in the market might view a certain share and we provide this commentary as a useful resource for investors. Content on this site does not in any way constitute a recommendation to buy, hold or sell any particular share. Investors should always seek professional advice before making any investment decisions.

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Printable version

Get quotes for Fisher & Paykel Healthcare Corporation L (FPH)

NZX Annoucements for FPH

9 Feb 2012	RELINT: FPH: Disclosure of Directors Relevant Interests
9 Feb 2012	GENERAL: FPH: CAREFUSION & FPH RENEW EXCLUSIVE DISTRIBUTION AGREEMENT
31 Jan 2012	SSH: FPH: SSH Mondrian Investment Partners Limited
11 Jan 2012	ALLOT: FPH: NOTIFICATION OF ISSUE OF SECURITIES